Audit of the clinical usefulness of a rapid qualitative ELISA screen for antimyeloperoxidase and antiproteinase 3 antibodies in the assessment of patients with suspected vasculitis

Journal of Clinical Pathology

Volumn 56, Issue 10, 2003, Pages 775-777

  Aslam, A ^a   Newman, T L ^a   Misbah, S A ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYELOPEROXIDASE; ENZYME ANTIBODY; ENZYME INHIBITOR; MYELOBLASTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CLINICAL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOLOGY; LABORATORY TEST; MEDICAL ASSESSMENT; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SCREENING; VASCULITIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MYELOBLASTIN; PEROXIDASE; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SERINE ENDOPEPTIDASES; VASCULITIS;

EID: 0141884384     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.56.10.775     Document Type: Article

References (5)

1. Franssen CFM, Stegeman CA, Kallenberg CGM, et al. Antiproteinase 3-and antimyeloperoxidase-associated vasculitis. Kidney Int 2000;57:2195-206.
2. Savige J, Gillis D, Benson E, et al. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 1999;111:507-13.
3. Westman KWA, Bygren PG, Eilert I, et al. Rapid screening assay for anti-GBM antibody and ANCAs; an important tool for the differential diagnosis of pulmonary renal syndromes. Nephrol Dial Transplant 1997;12:1863-8.
4. Savige J, Davies D, Falk RJ, et al. Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int 2000;57:846-62.
5. Stone JH, Talor M, Stebbing J, et al. Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions. Arthritis Care Res 2000;13:424-33.